Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    10053178 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome
Conditions: JOB's Syndrome;   Hyper-IgE Recurrent Infection Syndrome;   Immune Deficiency
Interventions: Drug: Ranitidine;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.